Moreover, melatonin reverses Aβ1–42‐induced neurotoxicity and memory impairment by increasing the levels of presynaptic proteins (Synaptophysin and SNAP25) and postsynaptic proteins (PSD95 and SNAP23) [37]. The gene discussed is DLG4; the disease is memory impairment.